10-hydroxycamptothecin has been researched along with Acute Promyelocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ling, YH; Nelson, JA; Tseng, MT | 1 |
| Andersson, BS; Ling, YH; Nelson, JA | 1 |
2 other study(ies) available for 10-hydroxycamptothecin and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Differentiation; DNA Topoisomerases, Type I; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; RNA, Neoplasm; Time Factors; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1991 |
DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Topics: Amsacrine; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Enzyme Inhibitors; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Mutation; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1990 |